University of Birmingham SDHA related tumorigenesis:

Purpose To evaluate the role of germline SDHA mutation analysis by (1) comprehensive literature review, (2) description of novel germline SDHA mutations and (3) in silico structural prediction analysis of missense substitutions in SDHA. A systematic literature review and a retrospective review of the molecular and clinical features of patients identified with putative germline variants in UK molecular genetic laboratories was performed. To evaluate the molecular consequences of SDHA missense variants, a novel model of the SDHA/B/C/D complex was generated and the structural effects of missense substitutions identified in the literature, our UK novel cohort and a further 32 “control missense vari-ants” were predicted by the mCSM computational platform. These structural predictions were correlated with the results of tumor studies and other bioinformatic predictions.

[1]  P. Meltzer,et al.  Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic. , 2016, JAMA oncology.

[2]  J. Valcárcel,et al.  The complete local genotype–phenotype landscape for the alternative splicing of a human exon , 2016, Nature Communications.

[3]  Douglas E. V. Pires,et al.  CSM-lig: a web server for assessing and comparing protein–small molecule affinities , 2016, Nucleic Acids Res..

[4]  Douglas E. V. Pires,et al.  In silico functional dissection of saturation mutagenesis: Interpreting the relationship between phenotypes and changes in protein stability, interactions and activity , 2016, Scientific Reports.

[5]  T. Frebourg,et al.  Exonic Splicing Mutations Are More Prevalent than Currently Estimated and Can Be Predicted by Using In Silico Tools , 2016, PLoS genetics.

[6]  G. Netto,et al.  Renal carcinoma associated with a novel succinate dehydrogenase A mutation: a case report and review of literature of a rare subtype of renal carcinoma. , 2015, Human pathology.

[7]  L. Hurst,et al.  Determinants of the Usage of Splice-Associated cis-Motifs Predict the Distribution of Human Pathogenic SNPs , 2015, Molecular biology and evolution.

[8]  P. Bénit,et al.  In Vivo Detection of Succinate by Magnetic Resonance Spectroscopy as a Hallmark of SDHx Mutations in Paraganglioma , 2015, Clinical Cancer Research.

[9]  Yingyong Hou,et al.  A novel germline mutation in SDHA identified in a rare case of gastrointestinal stromal tumor complicated with renal cell carcinoma. , 2015, International journal of clinical and experimental pathology.

[10]  W. Dinjens,et al.  Succinate Dehydrogenase (SDH)-Deficient Pancreatic Neuroendocrine Tumor Expands the SDH-Related Tumor Spectrum. , 2015, The Journal of clinical endocrinology and metabolism.

[11]  J. Ross,et al.  A Novel SDHA-deficient Renal Cell Carcinoma Revealed by Comprehensive Genomic Profiling , 2015, The American journal of surgical pathology.

[12]  Emma M. Rath,et al.  Structural and functional consequences of succinate dehydrogenase subunit B mutations. , 2015, Endocrine-related cancer.

[13]  A. Tischler,et al.  SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T) , 2015, Modern Pathology.

[14]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[15]  C. Stratakis,et al.  Metabolome Profiling by HRMAS NMR Spectroscopy of Pheochromocytomas and Paragangliomas Detects SDH Deficiency: Clinical and Pathophysiological Implications12 , 2015, Neoplasia.

[16]  W. Dinjens,et al.  Toward an improved definition of the genetic and tumor spectrum associated with SDH germ-line mutations , 2014, Genetics in Medicine.

[17]  Douglas E. V. Pires,et al.  Platinum: a database of experimentally measured effects of mutations on structurally defined protein–ligand complexes , 2014, Nucleic Acids Res..

[18]  J. Lasota,et al.  Succinate dehydrogenase deficient gastrointestinal stromal tumors (GISTs) - a review. , 2014, The international journal of biochemistry & cell biology.

[19]  Douglas E. V. Pires,et al.  DUET: a server for predicting effects of mutations on protein stability using an integrated computational approach , 2014, Nucleic Acids Res..

[20]  T. Dwight,et al.  Succinate Dehydrogenase Deficiency Is Rare in Pituitary Adenomas , 2014, The American journal of surgical pathology.

[21]  L. Hurst,et al.  The evolution, impact and properties of exonic splice enhancers , 2013, Genome Biology.

[22]  Douglas E. V. Pires,et al.  mCSM: predicting the effects of mutations in proteins using graph-based signatures , 2013, Bioinform..

[23]  T. Frebourg,et al.  Functional Analysis of a Large set of BRCA2 exon 7 Variants Highlights the Predictive Value of Hexamer Scores in Detecting Alterations of Exonic Splicing Regulatory Elements , 2013, Human mutation.

[24]  Laurence Amar,et al.  SDH mutations establish a hypermethylator phenotype in paraganglioma. , 2013, Cancer cell.

[25]  U. Srirangalingam,et al.  Evaluation of SDHB, SDHD and VHL gene susceptibility testing in the assessment of individuals with non‐syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma , 2013, Clinical endocrinology.

[26]  M. Korbonits,et al.  A comprehensive next generation sequencing-based genetic testing strategy to improve diagnosis of inherited pheochromocytoma and paraganglioma. , 2013, The Journal of clinical endocrinology and metabolism.

[27]  T. Dwight,et al.  Familial SDHA mutation associated with pituitary adenoma and pheochromocytoma/paraganglioma. , 2013, The Journal of clinical endocrinology and metabolism.

[28]  R. Casadio,et al.  Analysis of all subunits, SDHA, SDHB, SDHC, SDHD, of the succinate dehydrogenase complex in KIT/PDGFRA wild-type GIST , 2013, European Journal of Human Genetics.

[29]  J. Prchal,et al.  A novel EPAS1/HIF2A germline mutation in a congenital polycythemia with paraganglioma , 2013, Journal of Molecular Medicine.

[30]  M. von Mehren,et al.  Succinate Dehydrogenase Deficiency in Pediatric and Adult Gastrointestinal Stromal Tumors , 2013, Front. Oncol..

[31]  M. O'sullivan,et al.  SDHA mutations in adult and pediatric wild-type gastrointestinal stromal tumors , 2013, Modern Pathology.

[32]  L. Lipton,et al.  Loss of SDHA Expression Identifies SDHA Mutations in Succinate Dehydrogenase–deficient Gastrointestinal Stromal Tumors , 2013, The American journal of surgical pathology.

[33]  S. George,et al.  Loss of expression of SDHA predicts SDHA mutations in gastrointestinal stromal tumors , 2013, Modern Pathology.

[34]  P. Meltzer,et al.  Immunohistochemical Loss of Succinate Dehydrogenase Subunit A (SDHA) in Gastrointestinal Stromal Tumors (GISTs) Signals SDHA Germline Mutation , 2013, The American journal of surgical pathology.

[35]  C. Stratakis,et al.  Succinate dehydrogenase (SDHx) mutations in pituitary tumors: could this be a new role for mitochondrial complex II and/or Krebs cycle defects? , 2012, Endocrine-related cancer.

[36]  N. Socci,et al.  SDHA loss of function mutations in a subset of young adult wild-type gastrointestinal stromal tumors , 2012, BMC Cancer.

[37]  M. Urioste,et al.  MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma , 2012, Clinical Cancer Research.

[38]  A. Astolfi,et al.  A distinct pediatric-type gastrointestinal stromal tumor in adults: potential role of succinate dehydrogenase subunit A mutations. , 2011, The American journal of surgical pathology.

[39]  Jingyue Ju,et al.  Quantitative evaluation of all hexamers as exonic splicing elements. , 2011, Genome research.

[40]  W. Dinjens,et al.  SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas. , 2011, The Journal of clinical endocrinology and metabolism.

[41]  R. Casadio,et al.  SDHA loss-of-function mutations in KIT-PDGFRA wild-type gastrointestinal stromal tumors identified by massively parallel sequencing. , 2011, Journal of the National Cancer Institute.

[42]  Gaël Varoquaux,et al.  The NumPy Array: A Structure for Efficient Numerical Computation , 2011, Computing in Science & Engineering.

[43]  Agnieszka Maliszewska,et al.  Research resource: Transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas. , 2010, Molecular endocrinology.

[44]  P. Bénit,et al.  SDHA is a tumor suppressor gene causing paraganglioma. , 2010, Human molecular genetics.

[45]  J. Mullikin,et al.  Genomic features defining exonic variants that modulate splicing , 2010, Genome Biology.

[46]  Patricia L. M. Dahia,et al.  Germline mutations in TMEM127 confer susceptibility to pheochromocytoma , 2010, Nature Genetics.

[47]  Fiona Douglas,et al.  Tumor risks and genotype–phenotype–proteotype analysis in 358 patients with germline mutations in SDHB and SDHD , 2010, Human mutation.

[48]  Steven P. Gygi,et al.  SDH5, a Gene Required for Flavination of Succinate Dehydrogenase, Is Mutated in Paraganglioma , 2009, Science.

[49]  R. Ferrell,et al.  Sequence variation in human succinate dehydrogenase genes: evidence for long-term balancing selection on SDHA , 2007, BMC Biology.

[50]  H. Prokisch,et al.  Leigh syndrome caused by mutations in the flavoprotein (Fp) subunit of succinate dehydrogenase (SDHA) , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[51]  E. Berry,et al.  3-Nitropropionic Acid Is a Suicide Inhibitor of Mitochondrial Respiration That, upon Oxidation by Complex II, Forms a Covalent Adduct with a Catalytic Base Arginine in the Active Site of the Enzyme* , 2005, Journal of Biological Chemistry.

[52]  P. Donnelly,et al.  A Fine-Scale Map of Recombination Rates and Hotspots Across the Human Genome , 2005, Science.

[53]  M. Raponi,et al.  Synonymous mutations in CFTR exon 12 affect splicing and are not neutral in evolution. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[54]  C. Eng,et al.  Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. , 2004, JAMA.

[55]  B. Lemire,et al.  The Quaternary Structure of the Saccharomyces cerevisiae Succinate Dehydrogenase , 2004, Journal of Biological Chemistry.

[56]  P. Rustin,et al.  Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. , 2003, Cancer research.

[57]  E S Husebye,et al.  Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. , 2001, American journal of human genetics.

[58]  D. Evans,et al.  Germline SDHD mutation in familial phaeochromocytoma , 2001, The Lancet.

[59]  Ulrich Müller,et al.  Mutations in SDHC cause autosomal dominant paraganglioma, type 3 , 2000, Nature Genetics.

[60]  B. Devlin,et al.  Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. , 2000, Science.

[61]  U. Shankavaram,et al.  Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma/paraganglioma-polycythemia , 2014, Journal of Molecular Medicine.

[62]  W. Boron,et al.  Medical physiology : a cellular and molecular approach , 2002 .